Buchang held its 2016 Annual Shareholder Meeting in May 2017, where it approved the payment of its FY2016 dividend. The Company will distribute a total cash dividend of RMB 1.1 billion, or RMB 16.14 for every 10 shares held (before tax). The dividend is expected to be distributed in July 2017.
About Buchang
Buchang Pharmaceuticals is one of the leading traditional Chinese medicine (TCM) companies in China. Buchang was founded in 1993 by Mr. Zhao Buchang and his eldest son, Mr. Zhao Tao. Starting as a small TCM drug manufacturer, Buchang has evolved into a sales and marketing powerhouse. The Company has the most extensive sales network amongst its peers in China, covering over 15,000 hospitals and 150,000 drug stores. The Company’s product portfolio consists of in-house developed products, as well as products that it acquired and turned into blockbusters. Buchang’s brand name is widely recognized by physicians and patients throughout China.